Quest Diagnostics Incorporated

DGX

$127.15

+22.76% (1 year change)

Avg closing price

Price range

Market Cap

$17.1 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

-

Total revenue in the last quarter.

Net Income

-

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$8.19

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$2.21 (1.74%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

15.53x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

-

Earnings before interest expenses and taxes in the last quarter.

Employees

47,000

The number of full time employees.

Revenue & Earnings

Balance Sheet

Quest Diagnostics Incorporated

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

News

Quest Diagnostics (NYSE:DGX) Stock Rating Reaffirmed by Wells Fargo & Company

Quest Diagnostics (NYSE:DGX) Stock Rating Reaffirmed by Wells Fargo & Company

Quest Diagnostics (NYSE:DGX)‘s stock had its “hold” rating reissued by analysts at Wells Fargo & Company in a note issued to investors on Friday, AnalystRatings.com reports. Several other research ...

Zolmax News Zolmax News, 3 days ago
Quest Diagnostics Inc (NYSE:DGX) CAO Michael J. Deppe Sells 10,450 Shares

Quest Diagnostics Inc (NYSE:DGX) CAO Michael J. Deppe Sells 10,450 Shares

Quest Diagnostics Inc (NYSE:DGX) CAO Michael J. Deppe sold 10,450 shares of the stock in a transaction that occurred on Wednesday, October 21st. The shares were sold at an average price of $125.00,...

US Banking News US Banking News, 5 days ago
Pathological Examination Market with (Covid-19) Impact Analysis: Top Industry Trends & Segments Forecast 2020-2027 | Quest Diagnostics, Sonic Healthcare Limited, Spectra Laboratories, Diagnostic Pathology Services

Pathological Examination Market with (Covid-19) Impact Analysis: Top Industry Trends & Segments Forecast 2020-2027 | Quest Diagnostics, Sonic Healthcare Limited, Spectra Laboratories, Diagnostic Pathology Services

Global pathological examination market has gained the interest of the healthcare industry due to its application in better treatment and care, and effective diagnosis using digital pathology to hel...

OpenPR OpenPR, 6 days ago